E-commerce Platform Compliance

Major e-commerce platforms operate supplement-category overlays that often exceed the regulatory minimum, with category-specific restrictions, claim policies, advertising rules and seller verification requirements that gate what brand-owners can sell, where, with what claims, and to whom. Platform de-listing or ad-account suspension is a significant commercial event often arriving with minimal warning, making platform compliance a first-class operational discipline alongside FDA, FTC and international regulatory compliance.

Amazon — the dominant US supplement marketplace — enforces restricted-product policies (banned ingredients including DMAA, ephedrine, several pre-workout compounds, kratom in most contexts), restricted health claims (specific disease and weight loss language), Brand Registry requirements (voluntary but practically essential for trademark protection, A+ Content, Sponsored Brands advertising and counterfeit removal), listing content rules, FBA labelling and shelf-life requirements, and recall and adverse event handling protocols. Listing suspensions are triggered by automated content scans, customer safety complaints, competitor-initiated reports or periodic category audits. Shopify DTC e-commerce faces Acceptable Use Policy restrictions, payment-processor onboarding constraints for higher-risk categories (CBD, sports nutrition), Federal Trade Commission Negative Option Rule and state-specific subscription cancellation requirements (California AB 390, New York and others), and chargeback ratio thresholds. TikTok Shop, Instagram Shopping and YouTube Shopping bring platform-specific creator and live-shopping content moderation challenges where host or influencer ad-libbed claims can introduce unsubstantiated or disease language creating both platform policy violations and FDA structure/function-vs-disease exposure.

Meta and Google operate the dominant supplement digital advertising channels with category-specific advertising policies — restricted ingredient and product categories, claim restrictions, targeting restrictions (no targeting based on health conditions), creative restrictions (no before/after imagery, no exploitation of insecurity), with enforcement through automated content review and human appeal where account suspension can be rapid and reinstatement uncertain. Marketplace adverse event intake is the AER channel brand-owners often miss — marketplace AER forwards arrive in commercial-team or seller-central inboxes, get triaged for commercial response, and only reach pharmacovigilance after the DSNDCPA 15-business-day Serious Adverse Event clock has expired. Defensible programmes route every marketplace and DTC AER channel directly into the AER intake pipeline alongside the label-mandated channels, maintain per-SKU per-platform approved claim and creative libraries, distribute pre-approved talking points to creator partners, and treat platform-specific compliance as integrated regulatory discipline rather than marketing operations.